Salarius Pharmaceuticals Signs Definitive Merger Agreement with Decoy Therapeutics
Decoy’s product pipeline targets unmet needs in respiratory infectious diseases and gastroenterology (GI) oncology indications.
Decoy Therapeutics | 14/01/2025 | By Aishwarya | 107
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy